Anti-rheumatic drugs: present deadlock and new vistas.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003300:Copper / Q000494:pharmacology; D005228:Fatty Acids, Essential / Q000494:pharmacology; D005260:Female; D005609:Free Radicals; D006046:Gold / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008297:Male; D010396:Penicillamine / Q000494:pharmacology; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D005228:Fatty Acids, Essential; D005609:Free Radicals; D007166:Immunosuppressive Agents; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D006046:Gold; D003300:Copper; D010396:Penicillamine